Article Text

Download PDFPDF
Outcome of smooth surface tunnel porous polyethylene orbital implants (Medpor SST) in children with retinoblastoma
  1. Youn Joo Choi1,
  2. Chaerin Park2,3,
  3. Hyun Chul Jin4,
  4. Ho-Kyung Choung3,5,
  5. Min Joung Lee6,
  6. Namju Kim3,7,
  7. Sang In Khwarg2,3,
  8. Young Suk Yu2,3
  1. 1Department of Ophthalmology, Soonchunhyang University Cheonan Hospital, Cheonan, Korea
  2. 2Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea
  3. 3Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea
  4. 4Department of Ophthalmology, Kong Eye Hospital, Seoul, Korea
  5. 5Department of Ophthalmology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea
  6. 6Department of Ophthalmology, Hallym Sacred Heart Hospital, Anyang, Korea
  7. 7Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea
  1. Correspondence to Dr Ho-Kyung Choung, Department of Ophthalmology, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, 39 Boramae-gil, Dongjak-gu, Seoul 156-707, Korea; hokyung214{at}


Aim To evaluate the surgical outcome after the insertion of smooth surface tunnel porous polyethylene orbital implants (Medpor SST) in children with retinoblastoma.

Methods 44 consecutive children with retinoblastoma who underwent primary enucleation and Medpor SST implantation at Seoul National University Hospital from November 2004 to August 2009, with at least 24 months of follow-up were included. A retrospective review of cases was performed.

Results Mean age at the time of surgery was 24.7 months (range 1–65 months). The diameter of the spherical implant was 20 mm in 36 patients (81.8%) and 18 mm in 8 patients (18.2%). During a mean follow-up period of 60.1 months (range 26–93 months), there were no cases of implant exposure, extrusion or infection. Transient conjunctival thinning developed in three patients, but all resolved with conservative treatment. Anophthalmic socket complications such as lower lid malposition (retraction or entropion) (n=10, 22.7%), blepharoptosis (n=8, 18.2%) and enophthalmos (n=2, 4.5%) developed, but most showed acceptable cosmesis.

Conclusions Medpor SST is relatively safe, allowing for a mean follow-up of 5 years in terms of implant exposure, and may be a good choice of orbital implant for children with retinoblastoma.

  • Eye (Globe)
  • Neoplasia
  • Orbit
  • Child health (paediatrics)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.